FACULTAD DE MEDICINA
Fakultatea
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosUniversity of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (24)
2024
-
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
OncoImmunology, Vol. 13, Núm. 1
-
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
Journal of Clinical Oncology, Vol. 42, Núm. 9, pp. 994-1000
2023
-
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer
Cancer, Vol. 129, Núm. 4, pp. 521-530
-
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
Biomarker Research
-
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3063-3071
2022
-
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1
-
First international workshop of the ATM and cancer risk group (4-5 December 2019)
Familial Cancer, Vol. 21, Núm. 2, pp. 211-227
-
Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology
Human reproduction (Oxford, England), Vol. 37, Núm. 11, pp. 2497-2502
2021
-
Role of stromal activin A in human pancreatic cancer and metastasis in mice
Scientific Reports, Vol. 11, Núm. 1
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Precision prevention and cancer interception: The new challenges of liquid biopsy
Cancer Discovery, Vol. 10, Núm. 11, pp. 1635-1644
-
The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma
Oncotarget, Vol. 11, Núm. 13, pp. 1172-1185
2019
-
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion
European Journal of Cancer, Vol. 120, pp. 54-64
2018
2013
-
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029
-
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study
Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 602-607
2011
-
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
PLoS Genetics, Vol. 7, Núm. 7
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
The Lancet, Vol. 378, Núm. 9793, pp. 771-784
-
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials
The Lancet, Vol. 378, Núm. 9793, pp. 771-784
2010
-
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Nature Genetics, Vol. 42, Núm. 5, pp. 426-429